Related Experiment Videos
Von Willebrand factor and thrombosis
Massimo Franchini1, Giuseppe Lippi
1Servizio di Immunoematologia e Trasfusione, Ospedale Policlinico, Azienda Ospedaliera di Verona, Piazzale L. Scuro, 10, 37134, Verona, Italy. mfranchini@mail.univr.it
Annals of Hematology
|March 29, 2006
Summary
Von Willebrand factor (VWF) plays a key role in blood clotting and thrombosis. High VWF levels are linked to arterial clots, while its role in venous clots requires more research.
Area of Science:
- Hematology
- Vascular Biology
- Thrombosis Research
Background:
- Von Willebrand factor (VWF) is crucial for primary hemostasis and acts as a factor VIII carrier.
- Abnormal VWF multimers are implicated in thrombotic thrombocytopenic purpura (TTP).
- Elevated plasma VWF levels correlate with increased arterial thrombosis risk.
Purpose of the Study:
- To review the multifaceted role of VWF in thrombogenesis.
- To discuss the association between VWF and both arterial and venous thrombosis.
- To explore paradoxical thrombotic events in patients with von Willebrand disease.
Main Methods:
- Literature review of existing studies on VWF and thrombosis.
- Analysis of VWF structure and physiological functions.
- Discussion of clinical implications and conflicting data.
Main Results:
- Unusually large VWF multimers are linked to TTP pathogenesis.
- High plasma VWF levels are associated with arterial thrombosis.
- Conflicting data exists regarding VWF's role in venous thrombosis.
Conclusions:
- VWF is pivotal in thrombogenesis, with implications for arterial and potentially venous thrombosis.
- Understanding VWF's complex role is essential for managing thrombotic disorders.
- Further research is needed to clarify VWF's contribution to venous thromboembolism.